Fig 3 neatly demonstrates that UV treatment stimulates PARN deadenylaes activitiy exactly when 3' end processing is inhibited, strongly suggesting that these two UV induced effects are coupled to the same RNA substrates. Furthermore by in vitro reconstitution experiments (Fig 4) recombinant CstF50 can be shown to stimulate PARN deadenylation activity.
The final biochemical data in this paper resolves the issue that PARN is also known to interact with CBC80. The data in Fig 5 shows that CBC80 and CstF50 act antagonistically in complex formation with PARN and also in stimulation of PARN deadenylase activity.
The final part of this study is perhaps the weakest data in the paper. Here it is shown that UV induced reduction in various endogenous mRNAs can be counteracted by siRNA knockdown of PARN. However it seems hard to unpick whether this effect is due to the above described UV induced CstF50:PARN interaction or whether this is simply due to the loss of a major mRNA degradation activity. Perhaps for these endogenous mRNA level experiments to make a clearer connection with the above data then over-expression of sub-domains of CstF50/PARN/CBC80 that may act as dominant negative inhibitors of the described protein:protein interactions would be a better approach than PARN knockdown.
Overall I feel that these studies provide a further fascinating twist to the effect that UV damage has of mRNA 3' end formation and degradation. Showing that PARN interacts with CstF50 following UV induction and that this stimulates PARN activity is in itself a very publishable data set. However if the endogenous mRNA studies could be extended as suggested above then the study would become even more significant.
Referee #2 (Remarks to the Author):
Recommendation: return for revisions Review: This is a very interesting study which implicates the PARN deadenylase as part of a network of interactions with CstF50, BARD1 and CBP80 in the UV-induced regulation of 3' end processing as well as deadenylase activity. A lot of strong in vitro biochemistry is included in the study and in many cases complimentary experiments were performed to give significant confidence in the results that were obtained. I have a few suggestions to polish/improve aspects of the study: 1. Fig. 1C -Is the level/wavelength of UV light used in these treatments sufficient to UV crosslink RNA-protein complexes in vivo? If so, the authors may need to formally rule out that the increase in protein co-immunoprecipitation is due to covalently-associated RNA oligomers oligos that are likely present on PARN and CstF64 and are non-specifically attracting RNA binding proteins in the assay. Perhaps this could be readily done by demonstrating that an unrelated RNA binding protein like PTB or hnRNP C is not co-precipitated in these assays. 2. Fig. 3B -my eyes may be deceiving me but I believe that the western blot data panels that demonstrate siRNA knockdown efficiency in 3B are simply a lighter exposure of the panel included as part of Fig. 2A . If this is indeed the case there is obviously no need to show both. 3. Fig. 4C -The data demonstrating a lack of influence of CST-50 on NTD-PARN are intriguing but I want to make sure that there is not a trivial explanation for the result that is obtained. Is it possible that the 4ng level of NTD-PARN is simply too low/limiting to have any demonstrable deadenylation activity in these assays? Can CstF50 activate when added to a level of NTD-PARN that clearly has some activity (e.g. 20ngs)? 4. Fig. 6 -The authors conclude in the text that there is an increase in RNA stability in these samples, but RNA levels were only assayed by qPCR in a single time point without blocking further transcription. Therefore the changes observed can formally be due to increased RNA synthesis or stability. Thus the conclusion that the effects observed are occurring at the level of RNA stability need to be toned down or supported by direct experiments that specifically assess RNA decay rates. In this manuscript, the groups of A. Virtanen and F. Kleiman suggest a connection between deadenylation and response to DNA damage. To reach this conclusion, the authors present data to support an interaction between the deadenylase PARN, the polyadenylation factor CstF50 and the protein BARD1 that is connected to the response to DNA damage. They also analyze RNA cleavage and deadenylation in vitro after DNA damage. Evidence for a biological relevance of this mechanism is provided by a RT-PCR analysis of some mRNAs. This is an interesting area. The data presented are not entirely convincing, however. First, the data presented to support an interaction between CstF50 and PARN suggest at best a very weak interaction. (E.G., in the pool down performed wit recombinant factors presented in Figure 1A , the authors have to use western blotting rather than Coomassie staining to reveal the interaction.) Moreover, It is unclear whether there is truly a direct interaction between these factors or if they could indirectly be associated through RNA. The authors indicate having treated samples with RNase A to exclude the latter possibility. However, long RNA fragments will still be present after RNase A digestion (e.g., poly(A) or other purine-rich sequences as given the specificity of RNase A). Those could induce non-specific co-precipitation of the proteins, including PARN and potentially CstF-50. This problem could be avoided by using a non-specific nuclease (e.g., micrococcal nuclease) and controls to show that RNA degradation is complete. Altogether, the authors should present more convincing evidence for a direct interaction between CstF-50 and PARN both using recombinant factors and by co-immunoprecipitation from cells. Optimally, the use of a CstF-50 mutant, specifically inactivated for its interaction with PARN, could be used to induce a dominant negative effect on DNA damage-induced deadenylation. The second problem resides in the deadenylation assays. In each of the figures presented, a small fraction of the substrate RNA is deadenylated while most of the RNA remains full length. It is, for example, unclear why deadenylation does not increase significantly with time ( Figure 3A) . The patterns presented seem in contradiction with those reported by others (e.g., Cap-dependent deadenylation of mRNA. Dehlin E, Wormington M, Kˆrner CG, Wahle E. EMBO J. 2000 Mar 1;19(5):1079-86), where PARN appears to have a more distributive action. In fact, with the data presented, it is not possible for the reader to ascertain that the reaction product detected results from deadenylation rather than internal RNA cleavage. Would-it even be possible that PARN by binding to CstF-50 and poly(A) stimulates the polyadenylation machinery to cleave the L3A30 substrate at the normal polyadenylation site? Overall, this manuscript represent a story of rather wide interest, but the data presented are not sufficiently convincing to support the conclusion proposed by the authors.
Other points: -Why were primary two-hybrid data demonstrating the CstF-50-PARN interaction not made available in Kleidman and Manley (1999) if the results were obtained in an experiment that was published? -Page 6 bottom, Figure 1B lane 7 and legend: According to what is written, the authors have tested as a control whether GST interacts with GST-CstF-50. This gives a negative result. This is highly surprising given that they seem to use beads with glutathione. Could the authors clarify this point? -Page 12, line 9 and Figure 4A : In contrast to the authors' statement, some deadenylated products are seen in lane 10 and 11 (compare with lane 2). How can this be explained? Is it really deadenylation or internal RNA cleavage? -Material and Methods: The structure of the L3A30 substrate is not described. How is it produced? Does it truly end by A residues? -Figure legends: Important information is not always provided. The authors should provide more technical details such that the readers can understand what has been done. - Figure 1 , 2, 3 and 5: Why is there a need to present twice the same data? (Once with a gel picture and once with a quantified graph.) This is using a lot of space for nothing. Unnecessary duplicated data should be move to supplementary material. - Figure 3 : To prove that deadenylation is occurring specifically, the authors should present the results obtained with a L3 substrate ending with a different tail (e.g., 30 Us). Please find attached to this letter the manuscript "Nuclear deadenylation/polyadenylation factors regulate 3' processing in response to DNA damage" by Murat A. Cevher, Xiokan Zhang, Sully Fernandez, Sergey Kim, Jorge Baquero, Per Nilsson, Sean Lee, Anders Virtanen, and Frida E. Kleiman, which I am resubmitting for consideration as an article in The EMBO Journal. In a previous submission to EMBO J the manuscript was returned with a review and recommended for revisions. In your response you mentioned that the referees found the work to be very interesting, but they also thought that further experimental analysis was necessary to make the study suitable for publication. More specifically, the reviewers requested further analysis of the deadenylation process including the use of dominant negative inhibitors to show the effect of their interaction on endogenous mRNAs in response to DNA damage.
The paper describes the unexpected association of the polyadenylation factor CstF with the deadenylation factor PARN. The data we present supports a model in which the function of this interaction is to repress the cleavage step of polyadenylation and to activate deadenylation upon DNA damage in the nucleus, representing a new mode of global regulation of gene expression. In this new version, we have modified our paper in response to the reviewer's comments. I will go through all this point-by-point below, but let me first summarize the major addition to the paper.
As recommended by Reviewers 1 and 3, this new version of the paper includes further analysis of the deadenylation process using cells expressing the BARD1 mutant T734A. Previously, we have shown that this dominant negative mutant of BARD1 is defective not only in the UV-induced phosporylation of BARD1 but also in DNA damage functions of BARD1, such as inhibition of mRNA 3' cleavage and degradation of RNAP II (Kim et al. 2006) . We also showed that the phosphorylation of BARD1 plays an important role in the BARD1/CstF interaction (Kim et al. 2006 ). In the previous version of this paper, we showed that the tumor suppressor BARD1, which is involved in the UV-induced inhibition of the cleavage step of polyadenylation, can activate PARN-mediated deadenylation in the presence of CstF-50. The most significant new finding in this version of the paper is our demonstration that the BARD1/CstF/PARN complex formation and the activation of deadenylation after UV treatment are abrogated in nuclear extracts from cells expressing the BARD1 mutant T734A ( Figure 5C ). We also provide evidence that cells expressing this BARD1 mutant and PARN siRNA-treated cells show similar pattern of post-transcriptional regulation of endogenous transcripts of housekeeping genes upon DNA damaging conditions ( Figure 6 ). These new results indicate that BARD1/CstF/PARN complex formation is involved in the decrease mRNA stability of housekeeping genes upon DNA damaging conditions, and thereby might contribute to the UV-induced decrease in the cellular levels of total mRNA. We also showed that BARD1/CstF/PARN complex can decrease the stability of short lived mRNAs involved in control of cell growth and differentiation, keeping their expression levels low in non-stress conditions.
I discuss these changes, as well as others, in more detail below. But I believe the use of the T734A BARD1 mutant go to the heart of the reviewers' concerns and together greatly strengthen the paper and enhance its general interest. Below I respond to the specific comments of the reviewers.
Reviewer 1:
Minor concerns: As the exogenous radiolabeled substrate used in the reactions is not polyadenylated, the effects shown in Figure 2 are direct on mRNA 3' cleavage and not on deadenylation. Besides the conditions used in this experiment are not favorable for polyadenylation, so the 3' cleaved products generated are not polyadenylated during the reaction Major concern: As discussed above, experiments addressing the role of BARD1/CstF/PARN complex formation in the UV-induced effects on endogenous transcripts have been included in the new version of the paper. For that purpose we used cells expressing the dominant negative BARD1 mutant T734A. Previously, we have shown that this BARD1 mutant is defective not only in the UVinduced phosporylation of BARD1 but also in DNA damage functions of BARD1, such as inhibition of mRNA 3' cleavage and degradation of RNAP II (Kim et al. 2006 ). In the previous version of this paper, we showed that the tumor suppressor BARD1, which is involved in the UV-induced inhibition of the 3' cleavage, can activate PARN-mediated deadenylation in the presence of CstF-50. Now, we show that nuclear extracts from cells expressing the BARD1 mutant T734A do not show the BARD1/CstF/PARN complex formation and the activation of deadenylation after UV treatment ( Figure 5C ). Using the cells expressing this BARD1 mutant, we also show that BARD1/CstF/PARN complex is required to decrease mRNA polyadenylation levels and mRNA stability of housekeeping genes upon DNA damaging conditions, and thereby contribute to the UV-induced decrease in the cellular levels of total mRNA. We also showed that BARD1/CstF/PARN complex can decrease the stability of short lived mRNAs involved in control of cell growth and differentiation, keeping their expression levels low in non-stress conditions.
Reviewer 2:
1. We agree that in principle the UV treatment could be sufficient to crosslink RNA-protein complexes in vivo. However, we have shown the interaction between CstF-50 and PARN by three assays: yeast two-hybrid screen, pull-down assays using RNase treated recombinant proteins, and coimmunoprecipitation assays using RNase treated nuclear extracts. All three assays showed the interaction, suggesting that it would be extremely surprising that RNA tethering survived in all these three assays. Besides not all the RNA binding proteins are pulled-down in our assays, for example, the co-immunoprecipitation of CBP80 component of cap binding complex CBC with PARN decreases in UV-treated samples ( Figure 5D ).
2. As it was suggested by this reviewer, we removed the Western blot panel from Figure 3B .
3. The reviewer is correct that CstF-50 could have an effect if increasing amounts of NTD-PARN were used. However, the left panel of Figure 4C (lane 2, L3 product) shows that 4 ng of NTD-PARN has some slight deadenylase activity. We used NTD-PARN to probe that the PARN/CstF-50 interaction has an important effect on the activation of PARN activity. When CstF-50 is added to full-length PARN the deadenylase activity increases up to twenty folds ( Figure 4A ). It is clear that similar amounts of CstF-50 are not able to activate NTD-PARN activity. In fact we have determined that the addition of CstF-50 (50 ng) to NTD-PARN (10 ng) does not have an effect on deadenylation. We agree that analyzing the effect of CstF-50 on higher concentrations of NTD-PARN is likely to be informative, but believe this is beyond the scope of the current manuscript.
4. As it was suggested by this reviewer, we have modified the terminology used in the text.
Minor comments: Figure 4C has been modified.
Reviewer 3:
General concern 1: First, we apologize that Fig 1B was not described adequately, and hope this figure is made clearer in the revised manuscript. Now we clarify in the figure legend that the panel on the left is a Western blot analysis of the protein-protein interaction and the one on the right is a Coomassie staining, showing the purity of the recombinant proteins used in the left panel.
Second, we have shown the interaction between CstF-50 and PARN by three assays: yeast two-hybrid screen, pull-down assays using RNase treated recombinant proteins ( Figure 1B) , and coimmunoprecipitation assays using RNase treated nuclear extracts ( Figures 1C, 3D and 5D ). All three assays showed the interaction, suggesting that it would be extremely surprising that RNA tethering survived in all these three assays. Besides not all the RNA binding proteins are pulleddown in our assays, for example, the co-immunoprecipitation of CBP80 with PARN decreases in UV-treated samples ( Figure 5D ).
Although we did not use a CstF-50 mutant in our studies as suggested by this reviewer, we did use a PARN derivative that encompasses the N-terminal region (NTD-PARN). The NTD-PARN derivative is inactive for its interaction with CstF-50 ( Figure 1B , lane 5) but it does not have any effect on functional assays, such as the 3' cleavage reaction ( Figure 2C ) and the deadenylation reaction ( Figure 4C ). Besides, in this new version of the paper we further analyze the deadenylation process including the use of dominant negative inhibitors (see Major concern, Reviewer 1).
General concern 2: Both the 3' cleavage reactions shown in Figure 2 and the deadenylation reactions shown in Figure 3 were done with limiting amounts of nuclear extracts. In those conditions, a longer incubation time is not necessarily expected to generate more cleaved or deadenylated products. It is possible that the deadenlyation activity might be significantly down after 1 hour of incubation. Complete deadenylation is observed using recombinant proteins in the reconstituted systems shown in Figures 4 and 5. As this is the first time that a deadenylation activity is reported in crude nuclear extracts from cells, we decided to include the data from Figure 3A to show the experimental conditions for this reaction.
Several elements indicate that the reaction products observed in our experiments are deadenylated rather than cleaved. First, we show that the products of the deadenylation of L3A30 migrate as L3 ( Figure 4A , lane 1). Second, nuclear extracts that are active for 3' cleavage do not show appearance of L3 product ( Figure 3C ), indicating that the L3A30 substrate is not cleaved in those conditions. This is probably due to the lack of the downstream elements in the L3A30 substrate that are required for the 3' cleavage reaction. Third, when either recombinant PARN alone or PARN/CstF-50 mix are used in the reconstituted deadenylation reactions our results do not show a distributive pattern of the cleaved product ( Figures 4A, 4C , and 5A), ruling out the idea that the binding of CstF-50 to PARN might activate the cleavage of L3A30 at the normal polyadenylation site. Finally, the assays presented in this paper have not been designed to distinguish between distributive vs processive action of PARN. To make such determinations the experiments should be performed differently as described in Martinez et al. (JBC, 2001 ). We agree with this reviewer that this is likely to be informative, but we believe this is beyond the scope of the current manuscript.
Other points: 1) We apologize that due to space limitations we did not describe properly why the two-hybrid data was not included in the former publication (Kleiman and Manley 1999) . Now the following information is included in this version of the paper: "To identify proteins that interact with the polyadenylation factor CstF-50, we performed some time ago a yeast two-hybrid screen and identified BRCA1-associated BARD1 as a prominent interactor (Kleiman and Manley 1999). We have recently revisited the primary data of this screen and realized that one of the most abundant cDNAs that were identified as an interactor of CstF-50 corresponded to the C-terminal fragment of PARN. PARN was not recognized at the time when the screen was performed as the amino acid sequence of PARN was not known until later. ………."
2) We apologize that Fig 1B (lane 7) was not described adequately (page 6 bottom), and hope this figure is made clearer in the revised manuscript. As suggested by this reviewer, the sentence has been modified as follows: "However, the derivative encompassing the N-terminal region of PARN did not bind either to GST-CstF-50 ( Figure 1B, lane 5) or to the GST alone (lane 7)". We have also modified the legend for Figure 1B as follows: "GST and GST-CstF-50 were used in "pull-down" assays with the indicated His-PARN derivatives."
3) We agree with the reviewer that a slight band of the size of the deadenylated products are seen in lanes 10 and 11 ( Figure 4A ). We consider that band background because a band of similar size and intensity is also observed in the untreated substrate ( Figure 4A , lane 2). This band is probably nonpolyadenylated substrate that contaminates L3A30. For the reasons explained in General concern 2, we do not believe that this is a CstF-50-dependent cleavage reaction. Supporting these arguments, increasing amounts of CstF-50 do not show increase in the intensity of the band of the size of the deadenylated products (compare lanes 10 to 11 in Figure 4A ). 4) We apologize that we did not described properly the structure of the L3A30 substrate. Now we have included references where the origin and structure are described (Aström et al., EMBO J. 1991). The substrate is a poly(A) ending substrate. 5) As it was suggested by this reviewer, we have modified the Figure legends to make them clearer. 6) As it was suggested by this reviewer, we have eliminated the quantified graph. However, we would like to point out that other reviewers consider important both presentations of the data. 7) As PARN is very well characterized ribonuclease and several studies have shown its preference for degrading poly(A) (Aström et al., EMBO J. 1991 , Aström et al., JBC 1992 , Korner and Wahle JBC 1997 , Martinez et al., JBC 2000 , the analysis of the specificity of the deadenylation reactions shown in this study is likely to be informative, but we believe this is beyond the scope of the current manuscript.
8) The same PARN samples were used in panels A and B from Figure 5 . The extremely slight differences observed are due to differences in the gel exposure. Although we agree that the samples should be analyzed in the same gel, there is a technical limitation of space. That is the reason we included in panel B the analysis of the reaction with limited amounts of PARN. The new version of the paper does not include the former Figure 5B due to space limitations. Now Figure 5 includes the analysis of the effect of UV-treatment on deadenylation and BARD1/CstF/PARN complex formation in extracts from cells expressing a dominant negative mutant of BARD1. 9) We modified the figures indicating quantities in ng for all the factors.
10) We have not tested the effect of capping on our model because it has been shown that CBC, more specifically CBP-80, can inhibit PARN activity independently of the cap structure (Balatsos et al. 2006) . Balatsos et al. showed that CBC inhibits PARN through a direct interaction without binding the cap. We have included this comment in the new version of the paper. 11) As UV treatment has an effect on the levels of housekeeping genes, we used as endogenous control the RT products of GAPDH from cells treated with control siRNA and not treated with UV. This protocol is recommended by the manufacturer (Helixis). The log value corresponding to GAPDH from cells treated with control siRNA and not treated with UV is cero. However, the values shown in Figure 6A have been adjusted to avoid the presentation of negative values. Results from real time-PCR are usually expressed as log. We apologize that we did not described properly the Figure 6B . As the protocol is extensively explained in Gomes et al. (2006) and due to the limited space, we just made reference to the original manuscript. Now we have included a better explanation of the experiment. Total nuclear RNA was purified from the cells and this sample was divided in two: one was untreated (total sample) and the second one was treated with Oligotex resins (polyA+ sample). Then RT reactions were performed using random primers and equal volume of both samples. Equal amounts of total or poly(A)+ cDNAs were used as a template in the PCR reactions with primers specific for GAPDH, β-actin, c-fos and c-myc mRNAs. Relative quantification of both cDNA samples was done by using standard curves of known amounts of total cDNA. The experiment that the reviewer proposed could have been a good alternative. However, RT-PCR reactions with oligo(dT) result in a smear due to the different size of fully extended polyadenylated forms, which makes difficult the quantification of the poly(A)+ fraction.
2nd Editorial Decision 18 November 2009
Thank you for submitting your revised manuscript to The EMBO Journal. It has been seen by one of the original referees, who unfortunately finds that several of the initial concerns have not been satisfactorily addressed. I would like to point out that the EMBO Journal normally allows for one round of revision, the reason for this is to ensure that the authors do what they can and are willing to do to satisfy the referees, and not allow several rounds revision that results in significant loss of everyone's time. If at this point the referees are not convinced then this is sufficient reason for the manuscript to be rejected.
As you will see from the comments below, there are still a number of concerns that have not been addressed, I have also discussed this with the Executive Editor who can also see problems and will not over-rule this trusted referee. However, given the interest in the study we would like to give you one more opportunity to address these issues. The concerns of this referee should be addressed, including the RNase issue and importantly both the technical and conceptual concerns with the dominant negative mutant, we need a better blot in Fig 5c and insight into how a loss of interaction mutant can function as a dominant negative.
I would therefore like to ask you consider the situation, if you are able to address the concerns in full and improve the data we would be willing to look at the study once more for a final time. I would like to point out that the referee would see it again. If you are unable to address the issues than I am afraid that we would not be able to publish the study in the EMBO Journal.
Yours sincerely, Editor
The EMBO Journal
REFEREE REPORTS
Referee #3 (Remarks to the Author):
F. Kleiman has provided a revised version of the manuscript, prepared by her group and the team of A. Virtanen, where they suggest a connection between deadenylation and response to DNA damage. It is really unfortunate that the authors failed to take seriously some of the comments raised by the referees (see details below). Also, the new data added by the authors bring more questions that answers. In these conditions, I do not believe that the revised manuscript is suitable for publication.
-Two referees criticized the data supporting the interaction between the deadenylase PARN and the polyadenylation factor CstF50 and were concerned that RNA may indirectly bridge these factors. In particular, as the authors had used RNase A in GST pull-down and co-immunoprecipitation experiments, I indicated that this was not a good argument because it is known that RNases A fails to degrade polypurine sequences, including poly(A), which is known to bind to the PARN deadenylase as a substrate. The authors' answer is that they have used three assays (i) two-hybrid (in the presence of RNA), (ii) GST pull-downs after RNase (RNase A) treatment and (iii) coimmunoprecipitation after RNase (RNase A) treatment. They indicate that the referees should be convinced that RNA tethering would be "extremely surprising". I cannot accept that the authors did not take into account my comment that RNase A fails to degrade polypurine sequences, including poly(A), and did not answer this specific point. Given the extremely inefficient pull-down observed with these factors, I reiterate that correct controls (e.g., using micrococcal nuclease as suggested in my review) should have been provided. -I was also concerned that the deadenylase activity shown did not display the characteristic of PARN, including distributivity. To demonstrate that the activity really results from deadenylation, I also requested a control reaction with a substrate ending with a different tail (e.g., 30 Us). The authors' answer is that the PARN reaction is sufficiently well known and that this control is therefore not necessary! This may be what the authors believe for themselves, but as a referee, I'm not convinced and I want to see this control. Moreover, the authors fail to answer why PARN appears processive in their hands (demonstrated by a few molecules fully deadenylated when most substrate is intact) even though it was described to be distributive by others (e.g., Cap-dependent deadenylation of mRNA. Dehlin E, Wormington M, Kˆrner CG, Wahle E. EMBO J. 2000 Mar 1;19(5):1079-86). They just indicate that the study of distributive vs. processive degradation is not the topic of this manuscript. This is correct but does not answer my concern! -I reported a problem with the control data shown in the original Figure 5B that did not match the corresponding reaction. The authors explain that this was simply due to differences in exposure and lack of space on the gel (poorly convincing argument when the gel as only 8 lanes!)... and removed the control panel. This is not a serious and acceptable answer. This control is appropriate: it should be provided and it should be convincing. -In the original manuscript, the description of Figure 6 was very poor and it was difficult to understand what the authors had done. In particular, it was unclear how the authors ascertained that poly(A) RNA recovery was quantitative. Hence, I suggested to compare RT-PCR reactions performed using total RNA with cDNA synthesis primed either with oligo(dT) or a gene specific primer and then the same set of oligonucleotides for amplification. The authors have now provided more details making the experiment understandable. They still fail, however, to indicate why poly(A) RNA recovery is quantitative. Moreover, they now indicate that they used the same AMOUNT of cDNA in their reactions. The basis for this is unclear: why should there be equal amount of cDNAs if one fraction had initially lower RNA concentration? Moreover, they indicate that the experiment that I suggested would give smears. This is incorrect as oligo(dT) would have been used only in the RT reaction.
To answer referee 1, the authors added a Panel (new Figure 5C ) with the analysis of the BARD1 T734A dominant negative mutant. They conclude that this mutant is unable to form a complex with CstF50 and PARN. This is not convincing because the blot shown in Figure 5C has a very heterogeneous background possibly with bubbles suggesting that PARN detection may not be quantitative. Moreover, the authors failed to analyze CstF50 and thus cannot reach any conclusion regarding this factor. Finally, if the authors' conclusion about the BARD1 mutant interaction was correct, the authors would have to explain how the BARD1 T734A mutant can exert a dominant negative action on CstF50/PARN with which it is unable to interact. Indeed, if even in the presence of BARD1 T734A, wild type BARD1 still present in these cells should associate with CstF50/PARN and modulate their activity.
Finally, the authors argue that the fact that PARN does interact with CstF50 was not reported in their original two-hybrid data because "the amino-acid sequence of PARN was not known until later". This is indeed possible even if the amino acid sequence of PARN was published in The EMBO Journal in 1998 (EMBO J. 1998 Sep 15; 17(18) :5427-37). Even though this point is not a criterion for acceptance/rejection, it still underlines a poor science ethic because the primary data concerning an abundant clone found in a screen should have nevertheless been reported in the original publication describing the screen, not been kept aside. Reviewer 3:
1-We apologize for not including micrococcal nuclease treatments in our pull-down experiments in the previous submission of this manuscript. This new version of the paper includes a pull-down assay using recombinant GST-CstF-50 and His-PARN treated with micrococcal nuclease (new Figure 1A , lower panel). We also treated the nuclear extracts from U2OS cells stably transfected with different BARD1 expression constructs with micrococcal nuclease in the coimmunoprecipitation assays shown in the new Figure 5C . In those assays, the formation of the CstF/PARN complex was analyzed in nuclear extracts from cells expressing either WT or T734A mutant of BARD1. Both experiments show that CstF and PARN can interact after the nuclease treatment, indicating that RNA tethering is not involved in the formation of this complex.
2-Why the deadenylase activity shown in this manuscript did not display the characteristic of PARN, including distributivity?
An important point to answer this request is to define what the deadenylase activity characteristic of PARN is. Our deadenylation assays look quite similar to the ones shown not only by Virtanen's group (Matinez et al. 2001 ) but also to the ones shown by Wahle's group (Korner et al. 1998 Figure  8B , Dehlin et al. 2000, Figure 4B , 6B). In fact, Wahle's group explained these discrepancies in their 2000 paper: "….The pattern of deadenylation observed here with capped, polyadenylated substrate RNAs might be considered evidence for a processive reaction mechanism, as full-length substrate and completely deadenylated product co-existed. However, the substrate RNAs are likely to be heterogenous due to incomplete capping, partially blocked 3' ends (Korner and Wahle 1997) and, possibly, conformational heterogeneity. Thus, conclusions regarding to processivity of PARN should not be drawn from the experiments presented here. When homopolymeric poly(A) containing a 5' monophosphate is used as the substrate, PARN acts distributively (Korner and Wahle 1997). Additional experiments are required to determine whether this distributive behavior is altered by the interaction of PARN with the cap or with other non-adenylate residues within the substrate………". As mentioned in the first response to the reviewer, the assays presented in this paper have not been designed to distinguish between distributive vs processive action of PARN. Besides, as mentioned before, others have published similar patterns of deadenylation for PARN.
The reviewer also raised the question that in each of the figures presented in this paper a small fraction of the substrate RNA is deadenylated while most of the RNA remains full-length.
That is not the case of Figures 4A and C and Figures 5A and 6C , where complete disappearance of substrate RNA and accumulation of fully deadenylated product is observed.
The reviewer also wonders why deadenylation does not increase significantly with time. In former Figure 3A , no changes were observed between the incubation times analyzed (1 and 4 hours). As explained in our former response to this reviewer, those reactions were done with limiting amounts of nuclear extracts. In those conditions, a longer incubation time is not necessarily expected to generate more cleaved or deadenylated products. It is possible that the deadenlyation activity might be significantly down after 1 hour of incubation. Consistent with this explanation, a clear increase in deadenylation is observed in a time course experiment using incubation times shorter than 1 hour (new Figure 3A, upper panel) .
The reviewer also point out that with the data presented it is not possible for the reader to ascertain that the reaction product detected results from deadenylation rather than internal RNA cleavage.
Several new experiments suggest that the reaction products observed in our experiments are deadenylated rather than cleaved. First, we show that the products of the deadenylation of L3(A 30 ) migrate as L3 ( Figure 4A, lane 1) . Second, previous observations have shown that PARN deadenylating activity is stimulated by a 5' end located cap structure (Dehlin et al. 2000 , Gao et al. 2000 , Martinez et al. 2000 , 2001 . In agreement with PARN being the responsible deadenylase in this study, we found that the UV-induced activation of deadenylation in NEs was enhanced by the presence of a 5' end located m7-guanosine cap structure on the L3(A 30 ) RNA substrate ( Figure 3A , lower panel). Interestingly, the cap-dependency is a characteristic of PARN deadenylase but not of mRNA 3' end processing in vitro (Ryner and Manley 1987) . Thus, the cap stimulatory effect is in agreement with PARN being the responsible nuclease in our studies. Third, as requested by this reviewer, an RNA substrate with a different tail (ML43G 15 ) was unaffected by incubating them with either a mix of recombinant PARN and CstF-50 ( Figure 4D , right panel) or NE of cells exposed to UV (new Figure 3E) . Fourth, and most importantly, the release of only 5'AMP mononucleotides was observed after the incubation of a poly(A)-tail labeled RNA substrate with recombinant PARN and CstF followed by one-dimensional TLC analysis (new Figure 4D , left panel). 5'AMP mononucleotides release was not observed when ML43G 15 substrate was used in the reaction. A complex pattern of bands would be expected if the reaction was cleavage.
The reviewer also raised the possibility that PARN by binding to stimulates the polyadenylation machinery to cleave the L3 (A 30 ) substrate at the normal polyadenylation site.
As pointed in our former response to this reviewer, nuclear extracts that are active for 3' cleavage of AdL3 substrate do not show appearance of L3 products when incubated with L3(A 30 ) substrate ( Figure 3C ), indicating that the L3(A 30 ) substrate is not cleaved in those conditions. Besides, and most importantly, the L3(A 30 ) substrate does not have the downstream elements that are required for the 3' cleavage reaction. Moreover, the use of either recombinant PARN alone or PARN/CstF-50 mix in the reconstituted deadenylation reactions displayed the same pattern of bands, the full-length substrate and the completely deadenylated product ( Figures 4A, 4C , and 5A), ruling out the idea that the binding of CstF-50 to PARN might activate the cleavage of L3(A 30 ) at the normal polyadenylation site. More importantly, our results in Figure 2C show that CstF50/PARN complex inhibits 3' cleavage rather than activating it.
3-The control that the addition of recombinant BARD1 does not affect the deadenylation reaction in vitro (shown in the first version of the paper as Figure 5B ) has been included in the new Figure 5A .
4-The reviewer suggested comparing RT-PCR reactions performed using total RNA with cDNA synthesis primed either with oligo (dT) or a gene specific primer and then the same set of oligonucleotides for amplification.
First, we apologize for the misunderstanding of the experiment proposed by the reviewer. Although the reviewer's suggestion could have been quite useful, the use of a specific primer for the cDNA synthesis would have limited our study of Figure 7B (former Figure 6B) As described in our former response to the reviewer, total nuclear RNA was purified from the cells and this sample was divided in two: one was treated with Oligotex resins (polyA+ sample) and the second one was untreated (total sample). Although the RNA samples analyzed were originally extracted from cell plates grown to a similar level of confluence, some differences were observed in the yield of extracted RNA, probably due to experimental manipulation and/or the treatment of the cells with different conditions (e.g. UV and different siRNAs). It is important to highlight that the results presented in Figure 7B are ratios between the qRT-PCR values obtained using polyA+ and total RNA from the same cell plate, so as long as the efficiency of the enzymatic reactions (RT and PCR) were kept constant the ratios should not have been modified. Keeping this in mind, the RT reactions were performed using random primers and equivalent amounts of RNA. Similar amounts of RNA were used in this enzymatic reaction to reach similar efficiency in the cDNA synthesis among different RNA samples (total and polyA+) obtained in different conditions (PARN/control siRNA, UV treatment, etc). Then, equal amounts of total or poly(A)+ cDNAs were used as a template in the PCR reactions with primers specific for GAPDH, β-actin, c-fos and c-myc mRNAs. Again, similar amounts of cDNA were used to obtain similar efficiency in the PCR reactions using cDNAs from different RNA samples. As mentioned before, relative quantification of both cDNA samples was done by using standard curves of known amounts of total cDNA. Basically, the use of equivalent amounts of RNA and cDNA in the transcriptase reverse and PCR reactions, respectively, kept constant the efficiency of the enzymatic reactions, allowing us to compare RNA samples from different cell culture plates and to keep the ratios unmodified. This explanation has been included in the new version of the paper.
5-We apologize that we did not describe properly the former Figure 5C (now 5C and D). Now we have included a better explanation of the experiments and a better image of the coimmunoprecipitation of PARN with the mutant BARD1. We also included images of the coimmunoprecipitation of CstF with the mutant BARD1, and the reciprocal co-immunoprecipation experiments using anti-CstF-64 antibodies. All together, these experiments show that neither CstF (as described before, Kim et al 2006) nor PARN coimmnuprecipitated with the BARD1 mutant T734A (Flag labeled). Extending those studies, using the reciprocal coimmunoprecipitation assays with antibodies against CstF-64, now we show that the BARD1 mutant T734A did not associate with the CstF/PARN complex after UV treatment ( Figure 5C , compare lanes 2 and 4). Importantly, this assay shows that NEs from cells expressing either the WT or the BARD1 mutant T734A showed the formation of the CstF/PARN complex after UV treatment (compare lanes 14 and 16), supporting the idea that BARD1 is not necessary for the CstF/PARN complex formation ( Figure 1A and E). Importantly, the UV-induced activation of deadenylation decreased almost 50% in NE from cells expressing the BARD1 mutant T734A compare to NE from cells expressing WT BARD1 ( Figure 5D ). This is consistent with the results observed using NE from cells that are depleted in BARD1 by siRNA treatment ( Figure 5B ). Taken together, the above results indicate that BARD1 plays an important role in the activation of PARN-mediated deadenylation after UV treatment through its interaction with CstF.
We agree with the reviewer that the results presented in this manuscript do not sufficiently support the idea that BARD1 T734A mutant functions as a dominant negative of the UV-induced deadenylation. Therefore, we have eliminated those remarks from the text in this new version of the manuscript and we have included a better explanation of our results. As this reviewer pointed, cells stably transfected with the T734A version of BARD1 also express the endogenous WT BARD1. While both WT and BARD1 mutant T734A can interact with BRCA1 (Kim et al. 2006) , only WT BARD1 can interact with CstF. In that scenario, the WT and BARD1 mutant T734A would compete for interaction with BRCA1. The mutant BARD1/BRCA1 heterodimer would generate a complex that would not interact with CstF after UV treatment, decreasing partially (~50%) the magnitude of the UV-induced activation of deadenylation. Taken together, the results shown in Figure 5 indicate that BARD1 plays an important role in the activation of PARN-mediated deadenylation after UV treatment through its interaction with CstF.
6-Finally, I would like to apologize again that PARN was not mentioned in the Science paper of 1999 as an interactor of CstF-50. Back then, when the yeast two-hybrid was performed, it was very common to publish a paper characterizing one interaction in detail, and leaving the others completely undescribed. The two hybrid screening usually shows a high level of false positives, requiring future studies to confirm most of the interactions. In fact, in that paper we clearly mentioned that BARD1 was ONE of the interactors found in the yeast two hybrid screening. I would like to remark that PARN sequence was probably published by the time we were already writing that paper. Nevertheless, few years later, when we went through our data of the CstF-50 interactors and realized that PARN was one of them, we published that information in our 2008 NAR paper (Mirkin et al. 2008 ).
3rd Editorial Decision 19 February 2010
Thank you for submitting your revised manuscript for consideration by the EMBO Journal. It has been re-evaluated by one of the original referees, and while most of the issues have been resolved, there is still one outstanding issue. I would like to stress at this point that this issue has been raised at each round of review and not satisfactorily addressed. At the EMBO Journal we are quite strict regarding our one-round of major revision, in the case of your manuscript we allowed a second round but this issue still remains unresolved. While we normally would reject a manuscript that has not been adequately revised after two rounds of revision, here it is something that can be remedied quite quickly but still must be addressed. I have discussed the matter with the referee involved, and we require specifically the following data, the amount of Poly(A) RNA purified in expts described Fig 6, this is important for the interpretation of the ratios. From the purification we need the relative amounts of Pol(A) RNA purified under each condition +/-UV and +/-siRNA as described in the referees comments below.
Should you be able to address this criticism in full, we would consider a final revised manuscript. When preparing your letter of response to the referees' comments, please bear in mind that this will form part of the Review Process File, and will therefore be available online to the community. For more details on our Transparent Editorial Process initiative, please visit our website: http://www.nature.com/emboj/about/process.html Thank you for the opportunity to consider your work for publication. I look forward to your revision.
Yours sincerely,
Editor
The EMBO Journal state that the results should be correct as long as the efficiencies of all enzymatic reactions are constant. While I agree that this is an essential parameter, the ratio of a given mRNA in the total to poly(A)+ RNA fractions may be altered if extractions of the two RNA population are not quantitative. Cells may have more or less poly(A)+ RNA relative to total RNA, especially after treatment with UV or some siRNA. Using the same amount of total to poly(A)+ RNA may introduce an artificial distortion of the ratio of these two populations. (Why should we a priori take for granted that cells in different conditions have the same ratio of total to poly(A)+ RNA???) If poly(A)+ RNA extraction was shown to be quantitative and the ratio of poly(A)+ to total RNA similar for each samples, this potential problem would disappear.
Altogether, the quality of the manuscript has globally improved even if some weaknesses persist. Most importantly, I remain unconvinced by the validity of the RT-QPCR analysis but decision of accepting or further revising this manuscript is now an editorial one.
Other points: Page 34: "the log value corresponding to this sample was cero ª should be changed to ´ the log value corresponding to this sample was zero ª. making its quantification difficult using photometric techniques. To avoid artificial distortion of the ratios, we used "equal volumes" of both the polyA+ RNA samples and the total RNA samples in RT reactions using random primers. Equal amounts of total or poly(A)+ cDNAs were used as a template in the PCR reactions with primers specific for GAPDH, β-actin, c-fos and c-myc mRNAs. Relative quantification of both cDNA samples was done by using standard curves of known amounts of total cDNA.
We have now included this information in the text in three sections (Results: second paragraph page 20; Material and Methods: Analysis of endogenous mRNAS by qRT-PCR; and Figure Legends: Figure 7B ) to make the experiments clearer.
Besides, as the reviewer suggested, we have recently analyzed the enrichment of different mRNAs in the poly(A) + RNA population using the same RNA samples described above by an alternative procedure. Briefly, similar amounts of the total RNA sample (2 mg) were used to synthesize cDNA either with random primers (total RNA) or oligo(dT) (polyA+ RNA). Relative quantification of both cDNA samples was done by using standard curves of known amounts of total cDNA. Same amounts of these RT reactions were used then in the qRT-PCR reaction with primers for each specific gene shown in Figure 7 . Similar results to the ones presented in Figure 7 were obtained when the polyA+ RNA/total RNA ratio was calculated in these conditions. Although these results are not included in this version of the manuscript, we could include them as supplementary data upon request.
I would like to clarify a minor point: we did not discuss the slight effect of BARD1 addition on PARN activity shown in Figure 5A because this effect is not concentrationdependent, suggesting that this is a non-specific effect on the PARN deadenylase activity.
